Pervasive financial ties between universities and the pharmaceutical industry are tainting biomedical research, according to a study published in The Journal of the American Medical Association last January.
No one — and certainly not NIH — is arguing that financialties between academic investigators and companies, which are pervasive in biomedical research, should be severed.